Bressler, Susan B.

An international classification and grading system for age-related maculopathy and age-related macular degeneration

Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 1,926

Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

Chen, W., Stambolian, D., Edwards, A. O., Branham, K. E., Othman, M., Jakobsdottir, J., Tosakulwong, N., Pericak-Vance, M. A., Campochiaro, P. A., Klein, M. L., et al. (2010) · Proceedings of the National Academy of Sciences

Retinal Diseases and TreatmentsGenetic Associations and Epidemiology

Cited by 506

Secondary Analyses of the Effects of Lutein/Zeaxanthin on Age-Related Macular Degeneration Progression: AREDS2 Report No. 3

Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology

Retinal Diseases and TreatmentsAntioxidant Activity and Oxidative Stress

Cited by 415

Relationship of Drusen and Abnormalities of the Retinal Pigment Epithelium to the Prognosis of Neovascular Macular Degeneration

Bressler, S. B. (1990) · Archives of Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 325

Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration

Bressler, S. B. (2009) · Ophthalmology

Retinal Diseases and TreatmentsAngiogenesis and VEGF in Cancer

Cited by 205

Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration

BRESSLER, N. M., SILVA, J. C., BRESSLER, S. B., FINE, S. L., & GREEN, W. R. (1994) · Retina

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 200

Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema

Bressler, S. B., Glassman, A. R., Almukhtar, T., Bressler, N. M., Ferris, F. L., Googe, J. M., Gupta, S. K., Jampol, L. M., Melia, M., & Wells, J. A. (2016) · American Journal of Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 139

Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

Altaweel, M. M., Daniel, E., Martin, D. F., Mittra, R. A., Grunwald, J. E., Lai, M. M., Melamud, A., Morse, L. S., Huang, J., Ferris, F. L., et al. (2015) · Ophthalmology

Retinal Diseases and TreatmentsRetinal Imaging and Analysis

Cited by 51

Vision-threatening lesions developing with longer-term follow-up after treatment of neovascular age-related macular degeneration

Tanaka, E., Chaikitmongkol, V., Bressler, S. B., & Bressler, N. M. (2015) · Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 39

Clinicopathologic studies of eyes that were obtained postmortem from four patients who were enrolled in the submacular surgery trials: SST Report No. 16

Grossniklaus, H. E., Wilson, D. J., Bressler, S. B., Bressler, N. M., Toth, C. A., Green, W. R., & Miskala, P. (2006) · American Journal of Ophthalmology

Retinal Diseases and TreatmentsRetinal and Macular Surgery

Cited by 33